Company / Return on Assets (ROA)
Zenas BioPharma, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-98.5%
FY2025
5-year range
-98.5% / -10.0%
FY2023-FY2025
Trend
-881.7%
vs FY2024
Sector context
#207 of 213
Health Care
What the data says
Return on Assets (ROA) changed -882% YoY in FY2025, a notable deviation from the 2-year average annual change of -400%.
Based on SEC 10-K filings.
-98.5% in FY2025.
Declined from -54.4% to -98.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 213This company -98.5% Sector average -24.1%
▼
-307.9% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 881.7% year-over-year.
- Currently 74.3pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -98.5% | -881.7% |
| FY2024 | -10.0% | +81.6% |
| FY2023 | -54.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026